229 related articles for article (PubMed ID: 19240026)
21. Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells.
Abdel Hadi L; Di Vito C; Marfia G; Ferraretto A; Tringali C; Viani P; Riboni L
PLoS One; 2015; 10(11):e0143384. PubMed ID: 26580959
[TBL] [Abstract][Full Text] [Related]
22. Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
Morii Y; Tsubaki M; Takeda T; Otubo R; Seki S; Yamatomo Y; Imano M; Satou T; Shimomura K; Nishida S
Eur J Pharmacol; 2021 May; 898():173957. PubMed ID: 33662352
[TBL] [Abstract][Full Text] [Related]
23. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin.
Sankala HM; Hait NC; Paugh SW; Shida D; Lépine S; Elmore LW; Dent P; Milstien S; Spiegel S
Cancer Res; 2007 Nov; 67(21):10466-74. PubMed ID: 17974990
[TBL] [Abstract][Full Text] [Related]
24. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.
Meng RD; Shelton CC; Li YM; Qin LX; Notterman D; Paty PB; Schwartz GK
Cancer Res; 2009 Jan; 69(2):573-82. PubMed ID: 19147571
[TBL] [Abstract][Full Text] [Related]
25. Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined.
Dillahunt SE; Sargent JL; Suzuki R; Proia RL; Gilfillan A; Rivera J; Olivera A
J Immunol; 2013 Mar; 190(5):2058-67. PubMed ID: 23359503
[TBL] [Abstract][Full Text] [Related]
26. [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98].
Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):566-570. PubMed ID: 28534337
[TBL] [Abstract][Full Text] [Related]
27. Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway.
Sui H; Pan SF; Feng Y; Jin BH; Liu X; Zhou LH; Hou FG; Wang WH; Fu XL; Han ZF; Ren JL; Shi XL; Zhu HR; Li Q
BMC Complement Altern Med; 2014 Aug; 14():279. PubMed ID: 25085593
[TBL] [Abstract][Full Text] [Related]
28. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
[TBL] [Abstract][Full Text] [Related]
29. Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Mondal S; Mandal C; Sangwan R; Chandra S; Mandal C
Mol Cancer; 2010 Sep; 9():239. PubMed ID: 20836852
[TBL] [Abstract][Full Text] [Related]
30. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro.
Yao C; Wu S; Li D; Ding H; Wang Z; Yang Y; Yan S; Gu Z
Mol Oncol; 2012 Aug; 6(4):392-404. PubMed ID: 22583777
[TBL] [Abstract][Full Text] [Related]
31. The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL.
Camaré C; Augé N; Pucelle M; Saint-Lebes B; Grazide MH; Nègre-Salvayre A; Salvayre R
Free Radic Biol Med; 2016 Apr; 93():204-16. PubMed ID: 26855418
[TBL] [Abstract][Full Text] [Related]
32. Subtype-specific translocation of the delta subtype of protein kinase C and its activation by tyrosine phosphorylation induced by ceramide in HeLa cells.
Kajimoto T; Ohmori S; Shirai Y; Sakai N; Saito N
Mol Cell Biol; 2001 Mar; 21(5):1769-83. PubMed ID: 11238914
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of ceramide glucosylation sensitizes lung cancer cells to ABC294640, a first-in-class small molecule SphK2 inhibitor.
Guan S; Liu YY; Yan T; Zhou J
Biochem Biophys Res Commun; 2016 Aug; 476(4):230-236. PubMed ID: 27221045
[TBL] [Abstract][Full Text] [Related]
34. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
[TBL] [Abstract][Full Text] [Related]
35. Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.
Gao H; Gao MQ; Peng JJ; Han M; Liu KL; Han YT
Acta Pharmacol Sin; 2017 Dec; 38(12):1618-1631. PubMed ID: 29119970
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.
Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD
Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547
[TBL] [Abstract][Full Text] [Related]
37. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
38. Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells.
Sobue S; Nemoto S; Murakami M; Ito H; Kimura A; Gao S; Furuhata A; Takagi A; Kojima T; Nakamura M; Ito Y; Suzuki M; Banno Y; Nozawa Y; Murate T
Int J Hematol; 2008 Apr; 87(3):266-75. PubMed ID: 18283525
[TBL] [Abstract][Full Text] [Related]
39. [Down-regulation of sphingosine kinase 1 (SphK1) enhances the chemosensitivity to cisplatin in human colon cancer RKO cells].
Qin L; Liu S; Qin M; Wu W; Qin N; Fu Z; Xu C; Huang J; Lai M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):623-629. PubMed ID: 28502300
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death.
Ametller E; García-Recio S; Pastor-Arroyo EM; Callejo G; Carbó N; Gascón P; Almendro V
Cancer Biol Ther; 2011 Jan; 11(1):4-13. PubMed ID: 20980803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
